Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06919172 · ClinicalTrials.gov registry record · NA

iTBS/fMRI Study of Apex Control

A NA study of Transcranial Magnetic Stimulation, sponsored by Florida State University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT06919172: Recruiting NA study of Transcranial Magnetic Stimulation, sponsored by Florida State University.

NCT06919172 is a NA study of Transcranial Magnetic Stimulation that is actively recruiting participants, run by Florida State University. The registered enrollment target is 40 participants, above the 36-participant average among 7 other Transcranial Magnetic Stimulation trials with a reported enrollment target (11% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06919172, a NA study of Transcranial Magnetic Stimulation, is actively recruiting participants, sponsored by Florida State University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

The objective of this study is to examine the effect of transcranial magnetic stimulation (TMS) on the prefrontal cortex and posterior parietal cortex.

Primary Outcome

blood oxygenation level dependent (BOLD) signal in areas of the prefrontal and posterior parietal cortex assessed with functional magnetic resonance imaging (fMRI) \[note, this measure has no units\]

Interventions

  • DEVICE transcranial magnetic stimulation

Study Locations (2)

Florida

  • Florida State University Psychology Department Building - Tallahassee
  • FSU MRI Facility - Tallahassee

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-01-06
Est. Completion 2026-11-30
Phase NA
Florida State University

219 total trials

What NCT06919172 shows while recruiting

NCT06919172 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, above the 36-participant average among 7 other Transcranial Magnetic Stimulation trials with a reported enrollment target (11% higher).

The record links to 1 condition, with Transcranial Magnetic Stimulation appearing as the primary indexed condition, and to 1 intervention - of which transcranial magnetic stimulation is the first listed.

NCT06919172 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06919172 about?

NCT06919172 is a clinical study titled "iTBS/fMRI Study of Apex Control". The objective of this study is to examine the effect of transcranial magnetic stimulation (TMS) on the prefrontal cortex and posterior parietal cortex.

What is the current status of trial NCT06919172?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-01-06. Estimated completion is 2026-11-30.

What conditions does trial NCT06919172 study?

This clinical trial studies the following conditions: Transcranial Magnetic Stimulation.

What interventions are being tested in trial NCT06919172?

The interventions under investigation include: transcranial magnetic stimulation (DEVICE).

Who is sponsoring clinical trial NCT06919172?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06919172 being conducted?

This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Transcranial Magnetic Stimulation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06919172, the US trial registry maintained by the National Library of Medicine. NCT06919172 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.